Ovation Science Expands with Planet 13 into Florida
Ovation Science (OTC:OVATF) has expanded its license agreement with Planet 13 Holdings to bring its patented Invisicare® topical and transdermal cannabis products to the Florida market. The products will be distributed across Planet 13's network of 33 Florida dispensaries, building on their successful collaboration in Nevada.
Florida represents a significant opportunity as the largest medical cannabis market in the US, projected to exceed $2.5 billion in cannabis sales in 2025. The state has almost one million registered patients and leads in topical sales nationwide. Ovation's Invisicare® technology demonstrates superior bioavailability with 82% cannabinoid penetration compared to less than 2% for competitors.
This expansion marks Ovation's third active market, alongside Nevada and Pennsylvania, with additional planned expansions in Missouri and Canada. The company will earn royalty income from Planet 13's sales in both Nevada and Florida under this expanded agreement.
Ovation Science (OTC:OVATF) ha ampliato il suo accordo di licenza con Planet 13 Holdings per introdurre i suoi prodotti topici e transdermici brevettati Invisicare® a base di cannabis nel mercato della Florida. I prodotti saranno distribuiti attraverso la rete di 33 dispensari di Planet 13 in Florida, rafforzando la loro collaborazione di successo in Nevada.
La Florida rappresenta un'opportunità significativa in quanto il più grande mercato di cannabis medica negli Stati Uniti, con proiezioni di vendita di cannabis superiori a 2,5 miliardi di dollari nel 2025. Lo stato conta quasi un milione di pazienti registrati e guida le vendite di prodotti topici a livello nazionale. La tecnologia Invisicare® di Ovation dimostra una bio-disponibilità superiore con una penetrazione del 82% dei cannabinoidi, rispetto a meno del 2% dei concorrenti.
Questa espansione segna il terzo mercato attivo per Ovation, insieme a Nevada e Pennsylvania, con ulteriori piani di espansione in Missouri e Canada. La società guadagnerà royalties dalle vendite di Planet 13 sia in Nevada che in Florida grazie a questo accordo ampliato.
Ovation Science (OTC:OVATF) ha ampliado su acuerdo de licencia con Planet 13 Holdings para llevar sus productos tópicos y transdérmicos de cannabis patentados Invisicare® al mercado de Florida. Los productos se distribuirán en la red de 33 dispensarios de Planet 13 en Florida, consolidando su exitosa colaboración en Nevada.
Florida representa una oportunidad significativa como el mayor mercado de cannabis medicinal en EE.UU., con ventas proyectadas que superan los 2.5 mil millones de dólares en 2025. El estado cuenta con casi un millón de pacientes registrados y lidera las ventas de productos tópicos a nivel nacional. La tecnología Invisicare® de Ovation muestra una bio-disponibilidad superior con un 82% de penetración de cannabinoides, en comparación con menos del 2% de sus competidores.
Esta expansión marca el tercer mercado activo para Ovation, junto con Nevada y Pensilvania, con planes adicionales de expansión en Missouri y Canadá. La compañía recibirá ingresos por regalías de las ventas de Planet 13 tanto en Nevada como en Florida bajo este acuerdo ampliado.
Ovation Science (OTC:OVATF)는 Planet 13 Holdings와의 라이선스 계약을 확대하여 특허받은 Invisicare® 국소 및 경피용 대마초 제품을 플로리다 시장에 선보입니다. 이 제품들은 플로리다에 있는 Planet 13의 33개 디스펜서리 네트워크를 통해 유통되며, 네바다에서의 성공적인 협력을 기반으로 합니다.
플로리다는 미국 최대 의료용 대마초 시장으로, 2025년 대마초 판매액이 25억 달러를 초과할 것으로 예상됩니다. 이 주에는 거의 백만 명의 등록 환자가 있으며, 전국적으로 국소 제품 판매를 선도하고 있습니다. Ovation의 Invisicare® 기술은 경쟁사 대비 82%의 우수한 카나비노이드 침투율을 보여주며, 경쟁사는 2% 미만에 불과합니다.
이번 확장은 네바다와 펜실베이니아에 이은 Ovation의 세 번째 활성 시장을 의미하며, 미주리와 캐나다에서 추가 확장 계획도 있습니다. 이 회사는 이번 확장된 계약에 따라 네바다와 플로리다에서 Planet 13의 판매로부터 로열티 수익을 얻을 예정입니다.
Ovation Science (OTC:OVATF) a élargi son accord de licence avec Planet 13 Holdings pour introduire ses produits topiques et transdermiques brevetés Invisicare® à base de cannabis sur le marché de la Floride. Les produits seront distribués dans le cadre du réseau de 33 dispensaires de Planet 13 en Floride, renforçant leur collaboration réussie au Nevada.
La Floride représente une opportunité majeure en tant que plus grand marché américain du cannabis médical, avec des ventes de cannabis prévues à plus de 2,5 milliards de dollars en 2025. L'État compte près d'un million de patients enregistrés et est leader des ventes de produits topiques au niveau national. La technologie Invisicare® d'Ovation offre une biodisponibilité supérieure avec une pénétration des cannabinoïdes de 82%, contre moins de 2% pour les concurrents.
Cette expansion marque le troisième marché actif d'Ovation, aux côtés du Nevada et de la Pennsylvanie, avec d'autres expansions prévues dans le Missouri et au Canada. La société percevra des revenus de redevances sur les ventes de Planet 13 au Nevada et en Floride dans le cadre de cet accord étendu.
Ovation Science (OTC:OVATF) hat seine Lizenzvereinbarung mit Planet 13 Holdings erweitert, um seine patentierten Invisicare® topischen und transdermalen Cannabisprodukte auf den Markt in Florida zu bringen. Die Produkte werden über das Netzwerk von 33 Planet 13-Dispensaries in Florida vertrieben und bauen auf ihrer erfolgreichen Zusammenarbeit in Nevada auf.
Florida stellt eine bedeutende Chance dar, da es der größte medizinische Cannabismarkt in den USA ist und für 2025 Cannabisverkäufe von über 2,5 Milliarden Dollar prognostiziert werden. Der Bundesstaat hat fast eine Million registrierte Patienten und führt landesweit die Verkaufszahlen für topische Produkte an. Ovations Invisicare®-Technologie zeigt eine überlegene Bioverfügbarkeit mit 82% Cannabinoid-Durchdringung im Vergleich zu weniger als 2% bei Wettbewerbern.
Diese Expansion markiert Ovations dritten aktiven Markt neben Nevada und Pennsylvania, mit weiteren geplanten Erweiterungen in Missouri und Kanada. Das Unternehmen wird unter dieser erweiterten Vereinbarung Lizenzgebühren aus den Verkäufen von Planet 13 in Nevada und Florida erhalten.
- Expansion into Florida, the largest US medical cannabis market with projected $2.5B in 2025 sales
- Superior product efficacy with 82% cannabinoid penetration vs competitors' 2%
- Access to Planet 13's extensive network of 33 Florida dispensaries
- Additional royalty income stream from Florida sales
- Proven success record with existing Nevada partnership
- Florida regulations restrict distribution to dispensary-manufactured products only
- Dependence on Planet 13's retail performance for revenue generation
- Highly competitive medical cannabis market in Florida
Expanded License Agreement Brings Ovation's Science-Based Topicals to Largest Medical Cannabis Market in the USA
VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / July 29, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC:OVATF) ("Ovation" or the "Company"), today announced an expanded license agreement with Planet 13 Holdings, Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13") to bring its patented Invisicare® topical and transdermal cannabis products to the Florida market. The agreement will make Ovation's science-backed topical products available across Planet 13's extensive network of 33 Florida dispensary locations, building on the companies' on-going successful collaboration with Planet 13 in Nevada where Ovation's topicals have achieved top sales rankings statewide.
Florida, a medical cannabis market with almost one million registered patients, is projected to exceed
"Planet 13's comprehensive Florida presence creates an ideal platform for our topical products," said Terry Howlett, Ovation's President. "Their success with our products in Nevada demonstrates the market demand for effective, science-based solutions. Our products will be sold exclusively under Planet 13's brand across all Florida locations, providing immediate market access for Ovation's proprietary formulations. We know customers in Florida will be excited to see proven, effective, science-based topicals that work for multiple conditions." He added, "Ovation will earn royalty income from Planet 13's sales now in both Nevada and Florida under this expanded license agreement, positively impacting our financial results and creating value for our shareholders."
"Our experience with Ovation's topicals in Nevada has been excellent and we are excited to expand into Florida with these products. We will be launching our branded topical line shortly, expanding our brand presence and satisfying an unmet need for exceptional topicals in Florida," said Lee Fraser, Chief Administrative Officer of Planet 13. "This partnership with Ovation marks an important revenue generating opportunity, optimizes our Florida production facility, and enhances our gross margins."
Proven Technology Platform
Ovation's competitive advantage centers on its patented Invisicare® skin delivery system, developed through over two decades of pharmaceutical research. Laboratory testing demonstrated dramatically superior bioavailability compared to leading competitors - with Ovation's formulations achieving
Growth Trajectory
The Florida launch with Planet 13 represents Ovation's third active market, joining existing states: Nevada (Planet 13) and Pennsylvania (PA Options for Wellness). Additional 2025 expansions are planned with licensees in Missouri and Canada, and other potential states, positioning the Company for accelerated revenue growth across multiple regulated jurisdictions. Ovation continues to seek growth opportunities in other legal markets both in the USA and internationally.
Statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
About Planet 13
Planet 13 is a vertically integrated cannabis company, with award-winning cultivation, production and dispensary operations across its locations in California, Nevada, Illinois, and Florida. Home to the nation's largest dispensary, located just off The Strip in Las Vegas, Planet 13 continues to expand its footprint with the recent debut of its first consumption lounge in Las Vegas, DAZED!, the opening of its first Illinois dispensary in Waukegan, bringing cannabis experiences to the Chicago metro area. Planet 13 operates dispensaries across Florida, a key market in its expansive footprint. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and innovative cannabis products. Licensed cannabis activity is legal in the states Planet 13 operates in but remains illegal under U.S. federal law. Planet 13's shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and are quoted on the OTCQX under the symbol PLNH. To learn more, visit Planet13.com.
About Ovation Science Inc.
Ovation Science Inc. and its wholly-owned subsidiary; Ovation Science USA Inc., is a research and development company that develops topical and transdermal CBD/THC and other cannabinoid products which are out-licensed and also distributed under Ovation's own brands; ARLO CBD Beauty and InVibe® MD ("wellness" line); all powered by its patented Invisicare® skin delivery technology. Invisicare enhances the delivery of ingredients to and through the skin and is protected by patents and proprietary formulations which cannot be duplicated. With over 20 years of pharmaceutical drug delivery experience, Ovation's management and science team have created a unique pipeline of proprietary medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from royalties on licensees' sales and the sale of Invisicare, along with revenue from its own product sales. Ovation has offices in Vancouver, Canada and Las Vegas, USA.
Stock symbols: CSE:OVAT and OTC:OVATF
Websites: CORPORATE: www.ovationscience.com
WELLNESS: www.invibemd.com BEAUTY: www.arlocbdbeauty.com
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of sales and acceptance of its products in any of the state or country cited, continued sales in dispensaries or in retail markets or expansion to other states or countries. There are no guarantees of future performance or changes to regulations. Ovation Science Inc. cautions that all forward-looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.'s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.
Neither the Canadian Securities Exchange, OTC Markets nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
CORPORATE and LICENSING INQUIRIES:
Doreen McMorran: info@ovationscience.com PH: 604-982-5700
SOURCE: Ovation Science Inc.
View the original press release on ACCESS Newswire
FAQ
What is the significance of Ovation Science's expansion into Florida's cannabis market?
How effective is Ovation Science's Invisicare technology compared to competitors?
How many dispensaries will carry OVATF products in Florida?
What is Ovation Science's current market presence in the US cannabis industry?
How will the Florida expansion affect OVATF's revenue?
